APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-iodinated X-ray Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-iodinated X-ray Contrast Agents Industry Growth and Trends Forecast to 2032

Report ID 174017620127 December 202593 pages

Choose your research edition.

Industry ResearchNon-iodinated X-ray Contrast Agents Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-iodinated X-ray Contrast Agents Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Non-iodinated X-ray Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-iodinated X-ray Contrast Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-iodinated X-ray Contrast Agents Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non-iodinated X-ray Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-iodinated X-ray Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-iodinated X-ray Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-iodinated X-ray Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-iodinated X-ray Contrast Agents include Bracco Diagnostics, Guerbet Group, Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qingdao Hongdie New Materials Co., Ltd., Shandong Shengli Pharmaceutical Co., Ltd., Taishan Xinning Pharmaceutical Co., Ltd. and Xi'an Disai Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-iodinated X-ray Contrast Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-iodinated X-ray Contrast Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-iodinated X-ray Contrast Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-iodinated X-ray Contrast Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-iodinated X-ray Contrast Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-iodinated X-ray Contrast Agents Market by Company

Bracco Diagnostics

Guerbet Group

Qinhuangdao Zizhu Pharmaceutical Co., Ltd.

Qingdao Hongdie New Materials Co., Ltd.

Shandong Shengli Pharmaceutical Co., Ltd.

Taishan Xinning Pharmaceutical Co., Ltd.

Xi'an Disai Biopharmaceutical Co., Ltd.

Non-iodinated X-ray Contrast Agents Segment by Type

Barium Sulfate Type I

Barium Sulfate Type II

Non-iodinated X-ray Contrast Agents Segment by Application

Hospital

Clinic

Other

Non-iodinated X-ray Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-iodinated X-ray Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-iodinated X-ray Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-iodinated X-ray Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-iodinated X-ray Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-iodinated X-ray Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Barium Sulfate Type I Table 2. Major Company of Barium Sulfate Type II Table 3. Global Non-iodinated X-ray Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 5. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-iodinated X-ray Contrast Agents Price by Type (2021-2026) & (US$/Unit) Table 9. Global Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (K Units) Table 10. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-iodinated X-ray Contrast Agents Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-iodinated X-ray Contrast Agents Price by Type (2027-2032) & (US$/Unit) Table 14. North America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 15. North America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 17. Europe Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 21. Latin America Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Type (2021-2026) & (US$ Million) Table 24. Non-iodinated X-ray Contrast Agents Industry Trends Table 25. Non-iodinated X-ray Contrast Agents Industry Drivers Table 26. Non-iodinated X-ray Contrast Agents Industry Opportunities and Challenges Table 27. Non-iodinated X-ray Contrast Agents Industry Restraints Table 28. Global Non-iodinated X-ray Contrast Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-iodinated X-ray Contrast Agents Revenue Market Share by Company (2021-2026) Table 30. Global Non-iodinated X-ray Contrast Agents Sales by Company (2021-2026) & (K Units) Table 31. Global Non-iodinated X-ray Contrast Agents Sales Share by Company (2021-2026) Table 32. Global Non-iodinated X-ray Contrast Agents Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Non-iodinated X-ray Contrast Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-iodinated X-ray Contrast Agents Major Company Production Sites and Headquarters Table 35. Global Non-iodinated X-ray Contrast Agents Company, Product Type & Application Table 36. Global Non-iodinated X-ray Contrast Agents Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-iodinated X-ray Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-iodinated X-ray Contrast Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-iodinated X-ray Contrast Agents Sales by Region (2021-2026) & (K Units) Table 41. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-iodinated X-ray Contrast Agents Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-iodinated X-ray Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Non-iodinated X-ray Contrast Agents Sales by Region (2027-2032) & (K Units) Table 46. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-iodinated X-ray Contrast Agents Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-iodinated X-ray Contrast Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Non-iodinated X-ray Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 52. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-iodinated X-ray Contrast Agents Price by Application (2021-2026) & (US$/Unit) Table 56. Global Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (K Units) Table 57. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-iodinated X-ray Contrast Agents Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-iodinated X-ray Contrast Agents Price by Application (2027-2032) & (US$/Unit) Table 61. North America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 62. North America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 64. Europe Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 68. Latin America Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Application (2021-2026) & (US$ Million) Table 71. Bracco Diagnostics Company Information Table 72. Bracco Diagnostics Business Overview Table 73. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio Table 75. Bracco Diagnostics Recent Development Table 76. Guerbet Group Company Information Table 77. Guerbet Group Business Overview Table 78. Guerbet Group Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio Table 80. Guerbet Group Recent Development Table 81. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information Table 82. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Business Overview Table 83. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 85. Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Development Table 86. Qingdao Hongdie New Materials Co., Ltd. Company Information Table 87. Qingdao Hongdie New Materials Co., Ltd. Business Overview Table 88. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 90. Qingdao Hongdie New Materials Co., Ltd. Recent Development Table 91. Shandong Shengli Pharmaceutical Co., Ltd. Company Information Table 92. Shandong Shengli Pharmaceutical Co., Ltd. Business Overview Table 93. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 95. Shandong Shengli Pharmaceutical Co., Ltd. Recent Development Table 96. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 97. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 98. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 100. Taishan Xinning Pharmaceutical Co., Ltd. Recent Development Table 101. Xi'an Disai Biopharmaceutical Co., Ltd. Company Information Table 102. Xi'an Disai Biopharmaceutical Co., Ltd. Business Overview Table 103. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio Table 105. Xi'an Disai Biopharmaceutical Co., Ltd. Recent Development Table 106. North America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 108. North America Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2021-2026) Table 109. North America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Non-iodinated X-ray Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 111. North America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Non-iodinated X-ray Contrast Agents Market Share by Country (2021-2026) Table 114. North America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Non-iodinated X-ray Contrast Agents Market Share Forecast by Country (2027-2032) Table 116. Europe Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 118. Europe Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2021-2026) Table 119. Europe Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Non-iodinated X-ray Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Non-iodinated X-ray Contrast Agents Market Share by Country (2021-2026) Table 124. Europe Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Non-iodinated X-ray Contrast Agents Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Share by Country (2021-2026) Table 134. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Share Forecast by Country (2027-2032) Table 136. Latin America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 138. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2021-2026) Table 139. Latin America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Non-iodinated X-ray Contrast Agents Market Share by Country (2021-2026) Table 144. Latin America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Non-iodinated X-ray Contrast Agents Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Share by Country (2021-2026) Table 154. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Non-iodinated X-ray Contrast Agents Distributors List Table 159. Non-iodinated X-ray Contrast Agents Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Non-iodinated X-ray Contrast Agents Image Figure 2. Global Non-iodinated X-ray Contrast Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-iodinated X-ray Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-iodinated X-ray Contrast Agents Sales (2021-2032) & (K Units) Figure 5. Barium Sulfate Type I Image Figure 6. Global Barium Sulfate Type I Sales YoY Growth (2021-2032) & (K Units) Figure 7. Barium Sulfate Type II Image Figure 8. Global Barium Sulfate Type II Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Non-iodinated X-ray Contrast Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-iodinated X-ray Contrast Agents Market Share by Type 2025 VS 2032 Figure 11. North America Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-iodinated X-ray Contrast Agents Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Non-iodinated X-ray Contrast Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Non-iodinated X-ray Contrast Agents Market Share by Application 2025 VS 2032 Figure 31. North America Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 32. North America Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application in 2025 Figure 33. Europe Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 34. Europe Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application in 2025 Figure 37. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Market Share in Value by Application in 2025 Figure 41. North America Non-iodinated X-ray Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Non-iodinated X-ray Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Non-iodinated X-ray Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Non-iodinated X-ray Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Non-iodinated X-ray Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Non-iodinated X-ray Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Non-iodinated X-ray Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Non-iodinated X-ray Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Non-iodinated X-ray Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Non-iodinated X-ray Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Non-iodinated X-ray Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Non-iodinated X-ray Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Non-iodinated X-ray Contrast Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Non-iodinated X-ray Contrast Agents Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Non-iodinated X-ray Contrast Agents Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Barium Sulfate Type I
  • Barium Sulfate Type II
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Bracco Diagnostics
  • Guerbet Group
  • Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
  • Qingdao Hongdie New Materials Co., Ltd.
  • Shandong Shengli Pharmaceutical Co., Ltd.
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Xi'an Disai Biopharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-iodinated X-ray Contrast Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-iodinated X-ray Contrast Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-iodinated X-ray Contrast Agents Market by Type
  6. 1.3.1 Barium Sulfate Type I
  7. 1.3.2 Barium Sulfate Type II
  8. 1.4 Global Non-iodinated X-ray Contrast Agents Market Size by Type
  9. 1.4.1 Global Non-iodinated X-ray Contrast Agents Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-iodinated X-ray Contrast Agents Industry Trends
  2. 2.2 Non-iodinated X-ray Contrast Agents Industry Drivers
  3. 2.3 Non-iodinated X-ray Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Non-iodinated X-ray Contrast Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-iodinated X-ray Contrast Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-iodinated X-ray Contrast Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Non-iodinated X-ray Contrast Agents Price (2021-2026)
  4. 3.4 Global Non-iodinated X-ray Contrast Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-iodinated X-ray Contrast Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Non-iodinated X-ray Contrast Agents Company, Product Type & Application
  7. 3.7 Global Non-iodinated X-ray Contrast Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-iodinated X-ray Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-iodinated X-ray Contrast Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-iodinated X-ray Contrast Agents Tier 1, Tier 2, and Tier 3
4 Non-iodinated X-ray Contrast Agents Regional Status and Outlook
  1. 4.1 Global Non-iodinated X-ray Contrast Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size by Region
  3. 4.2.1 Global Non-iodinated X-ray Contrast Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-iodinated X-ray Contrast Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-iodinated X-ray Contrast Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Region
  7. 4.3.1 Global Non-iodinated X-ray Contrast Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-iodinated X-ray Contrast Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-iodinated X-ray Contrast Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-iodinated X-ray Contrast Agents by Application
  1. 5.1 Non-iodinated X-ray Contrast Agents Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Non-iodinated X-ray Contrast Agents Market Size by Application
  6. 5.2.1 Global Non-iodinated X-ray Contrast Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Non-iodinated X-ray Contrast Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Non-iodinated X-ray Contrast Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bracco Diagnostics
  2. 6.1.1 Bracco Diagnostics Company Information
  3. 6.1.2 Bracco Diagnostics Business Overview
  4. 6.1.3 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bracco Diagnostics Non-iodinated X-ray Contrast Agents Product Portfolio
  6. 6.1.5 Bracco Diagnostics Recent Developments
  7. 6.2 Guerbet Group
  8. 6.2.1 Guerbet Group Company Information
  9. 6.2.2 Guerbet Group Business Overview
  10. 6.2.3 Guerbet Group Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guerbet Group Non-iodinated X-ray Contrast Agents Product Portfolio
  12. 6.2.5 Guerbet Group Recent Developments
  13. 6.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd.
  14. 6.3.1 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  18. 6.3.5 Qinhuangdao Zizhu Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Qingdao Hongdie New Materials Co., Ltd.
  20. 6.4.1 Qingdao Hongdie New Materials Co., Ltd. Company Information
  21. 6.4.2 Qingdao Hongdie New Materials Co., Ltd. Business Overview
  22. 6.4.3 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Qingdao Hongdie New Materials Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  24. 6.4.5 Qingdao Hongdie New Materials Co., Ltd. Recent Developments
  25. 6.5 Shandong Shengli Pharmaceutical Co., Ltd.
  26. 6.5.1 Shandong Shengli Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shandong Shengli Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shandong Shengli Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  30. 6.5.5 Shandong Shengli Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Taishan Xinning Pharmaceutical Co., Ltd.
  32. 6.6.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Taishan Xinning Pharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  36. 6.6.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Xi'an Disai Biopharmaceutical Co., Ltd.
  38. 6.7.1 Xi'an Disai Biopharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Xi'an Disai Biopharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Xi'an Disai Biopharmaceutical Co., Ltd. Non-iodinated X-ray Contrast Agents Product Portfolio
  42. 6.7.5 Xi'an Disai Biopharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Non-iodinated X-ray Contrast Agents Sales by Country
  2. 7.1.1 North America Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-iodinated X-ray Contrast Agents Market Size by Country
  6. 7.2.1 North America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-iodinated X-ray Contrast Agents Sales by Country
  2. 8.1.1 Europe Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-iodinated X-ray Contrast Agents Market Size by Country
  6. 8.2.1 Europe Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country
  2. 9.1.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-iodinated X-ray Contrast Agents Sales by Country
  2. 10.1.1 South America Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-iodinated X-ray Contrast Agents Market Size by Country
  6. 10.2.1 South America Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country
  2. 11.1.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-iodinated X-ray Contrast Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-iodinated X-ray Contrast Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-iodinated X-ray Contrast Agents Value Chain Analysis
  2. 12.1.1 Non-iodinated X-ray Contrast Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-iodinated X-ray Contrast Agents Production Mode & Process
  7. 12.2 Non-iodinated X-ray Contrast Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-iodinated X-ray Contrast Agents Distributors
  10. 12.2.3 Non-iodinated X-ray Contrast Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst